Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C7H5I2NO3.C4H11NO2 |
| Molecular Weight | 510.0641 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OCCNCCO.OC(=O)CN1C=C(I)C(=O)C(I)=C1
InChI
InChIKey=RERHJVNYJKZHLJ-UHFFFAOYSA-N
InChI=1S/C7H5I2NO3.C4H11NO2/c8-4-1-10(3-6(11)12)2-5(9)7(4)13;6-3-1-5-2-4-7/h1-2H,3H2,(H,11,12);5-7H,1-4H2
| Molecular Formula | C4H11NO2 |
| Molecular Weight | 105.1356 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | C7H5I2NO3 |
| Molecular Weight | 404.9284 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Iodopyracet (Diodone) is a radiocontrast agent used in urography before 1950. Renal clearance of iodopyracet is characterized by supply-limited elimination at low plasma concentrations and capacity-limited elimination at high plasma levels. Iodopyracet to be an effective agent for the estimation of renal plasma flow and tubular function has been used extensively in physiological studies. In 1945 was found, that p-aminohippuric acid was in some ways superior to diodone for these estimations in man because the urine and plasma blanks are small and because diodone penetrates human red blood cells whereas p-aminohippuric acid does not.
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL1777665 Sources: https://www.ncbi.nlm.nih.gov/pubmed/14734677 |
Doses
| Dose | Population | Adverse events |
|---|---|---|
10 g single, intravenous Dose: 10 g Route: intravenous Route: single Dose: 10 g Sources: |
unhealthy |
Other AEs: Nausea and vomiting, Urticaria... Other AEs: Nausea and vomiting (severe, 2 patients) Sources: Urticaria (8 patients) Sleepiness (34 patients) |
AEs
| AE | Significance | Dose | Population |
|---|---|---|---|
| Sleepiness | 34 patients | 10 g single, intravenous Dose: 10 g Route: intravenous Route: single Dose: 10 g Sources: |
unhealthy |
| Urticaria | 8 patients | 10 g single, intravenous Dose: 10 g Route: intravenous Route: single Dose: 10 g Sources: |
unhealthy |
| Nausea and vomiting | severe, 2 patients | 10 g single, intravenous Dose: 10 g Route: intravenous Route: single Dose: 10 g Sources: |
unhealthy |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/2706315
3.0 g, administered i.v.
Route of Administration:
Intravenous
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 06:52:02 GMT 2025
by
admin
on
Wed Apr 02 06:52:02 GMT 2025
|
| Record UNII |
ZTK4026YJ5
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C28500
Created by
admin on Wed Apr 02 06:52:02 GMT 2025 , Edited by admin on Wed Apr 02 06:52:02 GMT 2025
|
||
|
WHO-VATC |
QV08AA10
Created by
admin on Wed Apr 02 06:52:02 GMT 2025 , Edited by admin on Wed Apr 02 06:52:02 GMT 2025
|
||
|
WHO-ATC |
V08AA10
Created by
admin on Wed Apr 02 06:52:02 GMT 2025 , Edited by admin on Wed Apr 02 06:52:02 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID1023154
Created by
admin on Wed Apr 02 06:52:02 GMT 2025 , Edited by admin on Wed Apr 02 06:52:02 GMT 2025
|
PRIMARY | |||
|
m6353
Created by
admin on Wed Apr 02 06:52:02 GMT 2025 , Edited by admin on Wed Apr 02 06:52:02 GMT 2025
|
PRIMARY | Merck Index | ||
|
1763
Created by
admin on Wed Apr 02 06:52:02 GMT 2025 , Edited by admin on Wed Apr 02 06:52:02 GMT 2025
|
PRIMARY | |||
|
4449
Created by
admin on Wed Apr 02 06:52:02 GMT 2025 , Edited by admin on Wed Apr 02 06:52:02 GMT 2025
|
PRIMARY | |||
|
DIODONE
Created by
admin on Wed Apr 02 06:52:02 GMT 2025 , Edited by admin on Wed Apr 02 06:52:02 GMT 2025
|
PRIMARY | |||
|
CHEMBL2110615
Created by
admin on Wed Apr 02 06:52:02 GMT 2025 , Edited by admin on Wed Apr 02 06:52:02 GMT 2025
|
PRIMARY | |||
|
9303
Created by
admin on Wed Apr 02 06:52:02 GMT 2025 , Edited by admin on Wed Apr 02 06:52:02 GMT 2025
|
PRIMARY | |||
|
D007468
Created by
admin on Wed Apr 02 06:52:02 GMT 2025 , Edited by admin on Wed Apr 02 06:52:02 GMT 2025
|
PRIMARY | |||
|
SUB07197MIG
Created by
admin on Wed Apr 02 06:52:02 GMT 2025 , Edited by admin on Wed Apr 02 06:52:02 GMT 2025
|
PRIMARY | |||
|
C75627
Created by
admin on Wed Apr 02 06:52:02 GMT 2025 , Edited by admin on Wed Apr 02 06:52:02 GMT 2025
|
PRIMARY | |||
|
300-37-8
Created by
admin on Wed Apr 02 06:52:02 GMT 2025 , Edited by admin on Wed Apr 02 06:52:02 GMT 2025
|
PRIMARY | |||
|
206-089-4
Created by
admin on Wed Apr 02 06:52:02 GMT 2025 , Edited by admin on Wed Apr 02 06:52:02 GMT 2025
|
PRIMARY | |||
|
DB13568
Created by
admin on Wed Apr 02 06:52:02 GMT 2025 , Edited by admin on Wed Apr 02 06:52:02 GMT 2025
|
PRIMARY | |||
|
ZTK4026YJ5
Created by
admin on Wed Apr 02 06:52:02 GMT 2025 , Edited by admin on Wed Apr 02 06:52:02 GMT 2025
|
PRIMARY | |||
|
100000082852
Created by
admin on Wed Apr 02 06:52:02 GMT 2025 , Edited by admin on Wed Apr 02 06:52:02 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE | |||
|
|
PARENT -> SALT/SOLVATE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |